Super excited to announce that our team received the notice of award from the
@theNCI
for our project investigating proteomic analysis of
#CSF
in
#gliomas
!
This has been a truly long journey filled with excitement, disappointments, and lots of learning opportunities.
Grateful
📢 Excited to share our multi-disciplinary, comprehensive review on CSF-based liquid biopsy in brain tumors, which allowed us to outline a potential roadmap to standardizing research done in this realm and optimize the integration of CSF analysis into routine clinical practice.
🚨🚨 our paper is out!
#proteomics
on CSF to diagnose malignant brain tumors, with insights gained into prognostics, using as little as 30uL of sample thanks to cutting edge technology
@KislingerThomas
! Potentially novel markers also identified 🔬🧠
70s Patient presented with progressive dementia and gait difficulties. Pre and post op MRI below (
#meningioma
). Always amazed at how much the brain can withstand.
#btsm
@PennStNeurosurg
While I am very proud to have contributed to this chapter on epilepsy in brain tumors with Dr. Ruda and Dr. Glantz, the highlight of this post is my 4-year-old saying " This book is kind of boring for kids", and my 6-year-old asking that I kindly "write children's books instead"
Got to catch up with Rockstar patient advocate (and awesome researcher!)
@TheLizArmy
. Love that I always learn so much from her every time we chat!
#BTSM
#SNO2022
@NeuroOnc
More exciting and encouraging data in the management of low grade gliomas, this time in children.
Most of these tumors have a genetic abnormality called BRAF mutations. Standard chemotherapy is currently not working and is toxic. The authors investigated whether 2 medications
A short but definitely memorable trip back to
@UofTNeuroSurge
to celebrate 100 years of history and innovation. Great to catch up with
@gelarehzadeh
who continues to lead the way in every regard, Ab Kulkarni my Program Director who played a great part in my training, mentors like
Wrapped up a productive meeting on brain metastases.
🧠Got to present our latest work on CSF liquid biopsy for brain metastases.
🧠 Learned about work other colleagues are doing in this realm.
🧠 Got a sneak peak at the concept of tumor treating fields and laser interstitial
On this first ever
#GBMDay
, the goal is to increase awareness for this deadly disease and to find better solutions. There has been little surgical innovation,
#survival
has not changed in ~15 years.
#patientexperience
matters!
Great CNS tumor section meeting, many thanks to the organizers
@CNS_Update
@NSTumorSection
@gelarehzadeh
and Drs. Galanis, Bettegowda, and Recinos. Great opportunity to learn about progress in the field, showcase our research, and enjoy great times with the team
@debaratibhanja
Excited to be launching GSUMIT, our pilot Phase II trial looking at feasibility and safety of a supramarginal resection of glioblastoma!
#glioblastoma
#surgery
#rct
Pleased to be an editor for
@FrontOncology
and share the impact (6.24) our journal has achieved publishing high-quality research that is open to all. Find out more:
When you hear your Neurosurgery colleague get so excited about a post op scan that you can hear them from 3 doors down: priceless!
#PatientCare
#Neurosurgeon
Check out our study on
#mentalhealth
diagnosis (MHD) and
#lowgradeglioma
. Using a health insurance database review,
@debaratibhanja
found 61% prevalence of new MHD in LGG. 16% were new within 12 mos of dx. Seizures associated with highest risk!
A good friend who is highly qualified for program director position was told to focus on family for time being instead (she is pregnant). Aren't we living in 2021? 🤔
Incredibly proud of Hannah Wilding
@PennStNeurosurg
presenting our work on predictors of
#brain
#metastases
from non small cell lung ca at
@NeuroOnc
@ASCO
joint meeting. Look out for her and her accomplishments in the years to come
Had the distinct pleasure of presenting on our surgical clinical trials and some of the nuances at the Ottawa neuroscience rounds with Dr.
@JahaniArezu
as a gracious host. I was fortunate that this coincided with the day Dr.
@gelarehzadeh
was giving her
#Gairdner
lecture where
Incredibly happy for those who matched today to Neurosurgery. You should be proud of all your hard work and perseverance!
#neurosurgery
#matchday
#residency
My 4 year old has been having temper tantrums lately about many life challenges, but her shadow not leaving her alone today was by far the most entertaining.
Superstar Ahmad Ozair
@NeuroAhmad
presenting safety and feasibility of ruxolitinib in high grade gliomas
@CNS_Update
. Looking forward to the phase 2 trial launching in 2024.
Congrats to all team members
@BrainTumorDoc
@yasmeenrauf
Excited to share our network meta-analysis, comparing the efficacy of treatments for non-small cell lung cancer brain metastases without an EGFR or Alk mutation. Threat 🧵
A relatively large retrospective paper showing that in patients withGrade 2 astrocytoma and the favorable prognostic marker of IDH mutation, chemotherapy and radiation can be spared until there's evidence of recurrence, in most cases. Specifically, this applies to patients who
Thank you to Sapienza group for publishing our experience in patients with adult-type diffuse IDH-mutant grade 2 gliomas: Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant gr…
Wishing everyone who celebrates Persian New year a happy
#Nowruz
. As this day also coincides with the official arrival of spring, I hope to see a year of health, peace and prosperity for humanity.
Please check out this exciting clinical trial by my brilliant friend and colleague
@NIH
Dr. Jackson, for patients with high grade glioma or diffuse mid line glioma.
#btsm
@DrSadhanaJ
Check out our systematic review and our take on the necessary approaches to combining immunotherapy regimens for glioblastoma
@NeuroOnc
@NSTumorSection
Rapid malignant progression of lower grade glioma: 50s male presents in status with top panel of images. Biopsy shows Gr 2 IDHwt Astro. Presents 2 mos later with speech deficits and bottom panel of images. Pathology GBM.
#BTSM
@PennStNeurosurg
@NSTumorSection
91% reduction in tumor volume through purely medical treatment for BRAF mutated craniopharyngioma- a traditionally difficult to operate tumor. Need to work toward liquid biopsy methods of detecting BRAF mut'n for better precision medicine.
#BTSM
@NEJM
Exciting residency interview day. Remarkable how each year the caliber of candidates just keeps getting better. Impressed by intelligence, hard work, and humanitarianism of this future generation!
#residency
#neurosurgery
#MedTwitter
May is
#BrainTumorAwarenessMonth
. Now more than ever it is important to advocate for people with 🧠tumors. Join me Tuesday May 5 at 5pm EST for an interactive webinar 👇on things to know about
#BrainTumor
and
#COVID
ー19. DM to register.
@EladLevyMD
@DrTobiasFunky
Not sure if you'd want to be in a program that "tests" you. Authenticity and genuineness with your future colleagues should be a key part of the decision
A great example of thinking outside the box to push the envelope for this terrible disease. Clearly the classic approaches that we have been trying have not been working. Thank you
@johnboockvar
for your innovation!
@BTSMchat
#btsm
Omentum is the fatty blanket that covers our intestines. It also is a rich source of immune cells that are needed to fight infection and cancers. Here we use it as a source of cancer fighting cells and to create new blood vessels that lack a blood brain barrier. Learn how we are